Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2019-09-23 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces that CARMAT has been "invited to present at the Ladenburg Thalmann Healthcare Conference." It details the date, time, and location of the presentation, and provides a link to follow it live. This structure—a brief announcement about an upcoming event or presentation, rather than the full content of a financial report or transcript—strongly indicates a communication intended to inform investors about corporate activity. This fits best under the category of a general regulatory announcement or a communication related to investor relations activities, but since it is a press release announcing participation in an investor conference, it is most closely aligned with general corporate communication. Given the options, and since it is not a formal financial filing (like 10-K, IR, ER), it falls under the general regulatory/announcement category. However, since it is a specific announcement about investor engagement, and not a formal filing, the most appropriate general category is RNS (Regulatory Filings) as a fallback for non-standard announcements, or potentially a very brief Investor Presentation (IP) if the announcement itself was the presentation material, but here it is an announcement *about* a presentation. Given the nature of press releases announcing participation in investor events, RNS is the safest general classification if a more specific investor relations code isn't available for 'conference participation announcement'. Since the document is short and announces an event rather than containing the full report, it is not an ER, IR, or IP. RNS is the best fit for a general press release announcement.
2019-09-23 English
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the success of a capital increase ("Offre Réservée de 60 M€") reserved for specialized and strategic investors. The content details the amount raised, the price per share, the use of funds, and the resulting shareholder structure changes. This clearly indicates a financing activity or capital structure change announcement, which aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it is a specific announcement about fundraising.
2019-09-19 French
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces the "success of its €60 million Reserved Offering for specialized and strategic investors." This clearly indicates a corporate action related to raising capital or changing the capital structure through the issuance of new shares. This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it involves share issuance, the primary focus is the successful completion of the financing event itself, rather than just a general share issue announcement (SHA) or a transaction in own shares (POS). It is a financing announcement, not a regulatory filing like a 10-K or an earnings release.
2019-09-19 English
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 1% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces the launch of a fundraising effort ('levée de fonds') targeting specialized and strategic investors for a minimum amount of 50 M€. It details the use of proceeds (clinical studies, industrialization, commercial preparation) and the terms of the private placement ('Offre Réservée'), including the price per share and commitments from existing and new shareholders. This clearly falls under the category of updates on company fundraising or capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it is specifically about a capital raise.
2019-09-18 French
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces the "launch of a capital raise of a minimum of €50m reserved for specialized and strategic investors." It details the terms, price, intended use of funds (clinical studies, industrial ramp-up), and commitments from existing and new investors. This content directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA).
2019-09-18 English
Inside Information / News release on accounts, results
Earnings Release Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and begins by stating, "CARMAT reports its 2019 half-year results and confirms its main development targets...". It presents key financial figures for the first half of 2019 (H1 2019), including a simplified income statement, and discusses clinical progress and strategy outlook. This structure—a brief announcement highlighting key figures for a specific interim period (half-year) rather than the comprehensive filing itself—is characteristic of an Earnings Release (ER). While it mentions the full half-year financial report was published separately, this document serves as the initial, high-level announcement of those results. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the press release summarizing the period's performance. H2 2019
2019-09-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.